ATE239703T1 - Azetidinderivate, deren herstellung und sie enthaltende arzneimittel - Google Patents

Azetidinderivate, deren herstellung und sie enthaltende arzneimittel

Info

Publication number: ATE239703T1
Authority: AT; Austria
Prior art keywords: production; products containing; medicinal products; azetidine derivatives; azetidine
Prior art date: 1998-09-11

Application number

AT99941728T

Other languages

English (en)

Inventor

Serge Mignani

Augustin Hittinger

Daniel Achard

Herve Bouchard

Jean Bouquerel

Marc Capet

Serge Grisoni

Jean-Luc Malleron

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-11

Filing date

1999-09-09

Publication date

2003-05-15

1999-09-09 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2003-05-15 Application granted granted Critical

2003-05-15 Publication of ATE239703T1 publication Critical patent/ATE239703T1/de

Links

HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical class C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 title 1
229940126601 medicinal product Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Oncology (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Ophthalmology & Optometry (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Obesity (AREA)
Addiction (AREA)
Hematology (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Otolaryngology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)

AT99941728T 1998-09-11 1999-09-09 Azetidinderivate, deren herstellung und sie enthaltende arzneimittel ATE239703T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR9811342A FR2783246B1 (fr)	1998-09-11	1998-09-11	Derives d'azetidine, leur preparation et les medicaments les contenant
US11992999P	1999-02-12	1999-02-12
PCT/FR1999/002147 WO2000015609A1 (fr)	1998-09-11	1999-09-09	Derives d'azetidine, leur preparation et les medicaments les contenant

Publications (1)

Publication Number	Publication Date
ATE239703T1 true ATE239703T1 (de)	2003-05-15

Family

ID=9530327

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99941728T ATE239703T1 (de)	1998-09-11	1999-09-09	Azetidinderivate, deren herstellung und sie enthaltende arzneimittel

Country Status (26)

Country	Link
EP (1)	EP1112251B1 (de)
JP (1)	JP4767413B2 (de)
CN (1)	CN1149191C (de)
AR (1)	AR021483A1 (de)
AT (1)	ATE239703T1 (de)
AU (1)	AU772025B2 (de)
BR (1)	BR9913592A (de)
CA (1)	CA2342739C (de)
CO (1)	CO5150230A1 (de)
CZ (1)	CZ301446B6 (de)
DE (1)	DE69907698T2 (de)
DK (1)	DK1112251T3 (de)
DZ (1)	DZ2887A1 (de)
ES (1)	ES2197666T3 (de)
FR (1)	FR2783246B1 (de)
HU (1)	HUP0103341A3 (de)
MA (1)	MA26685A1 (de)
MY (1)	MY119150A (de)
PL (1)	PL198526B1 (de)
PT (1)	PT1112251E (de)
RU (1)	RU2230739C2 (de)
TN (1)	TNSN99168A1 (de)
TR (1)	TR200100693T2 (de)
TW (1)	TW530046B (de)
WO (1)	WO2000015609A1 (de)
ZA (1)	ZA200102003B (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2799124B1 (fr)	1999-10-01	2004-08-13	Sanofi Synthelabo	Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour la preparation de medicaments
BR0112883A (pt)	2000-08-01	2003-06-24	Ono Pharmaceutical Co	Composto de derivado de 3,4-diidroisoquinolina e um agente farmacêutico compreendendo o mesmo como ingrediente ativo
FR2814678B1 (fr) *	2000-10-04	2002-12-20	Aventis Pharma Sa	Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite
FR2829028B1 (fr) *	2001-08-29	2004-12-17	Aventis Pharma Sa	Association d'un antagoniste du recepteur cb1 et d'un produit qui active la neurotransmission dopaminergique dans le cerveau, les compositions pharmaceutiques les contenant et leur utilisation pour le traitement de la maladie de
US7109216B2 (en)	2001-09-21	2006-09-19	Solvay Pharmaceuticals B.V.	1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
FR2833842B1 (fr) *	2001-12-21	2004-02-13	Aventis Pharma Sa	Compositions pharmaceutiques a base de derives d'azetidine
AU2003217961B2 (en)	2002-03-08	2008-02-28	Signal Pharmaceuticals, Llc	Combination therapy for treating, preventing or managing proliferative disorders and cancers
US6825209B2 (en)	2002-04-15	2004-11-30	Research Triangle Institute	Compounds having unique CB1 receptor binding selectivity and methods for their production and use
PL375441A1 (en)	2002-07-29	2005-11-28	F.Hoffmann-La Roche Ag	Novel benzodioxoles
US7129239B2 (en)	2002-10-28	2006-10-31	Pfizer Inc.	Purine compounds and uses thereof
US7247628B2 (en)	2002-12-12	2007-07-24	Pfizer, Inc.	Cannabinoid receptor ligands and uses thereof
CN101012193A (zh)	2003-01-02	2007-08-08	霍夫曼-拉罗奇有限公司	新cb 1受体反激动剂
US7135488B2 (en)	2003-01-02	2006-11-14	Hoffmann-La Roche Inc.	Pyrrolyl-thiazole derivatives
US7329658B2 (en)	2003-02-06	2008-02-12	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
US7268133B2 (en)	2003-04-23	2007-09-11	Pfizer, Inc. Patent Department	Cannabinoid receptor ligands and uses thereof
US7145012B2 (en)	2003-04-23	2006-12-05	Pfizer Inc.	Cannabinoid receptor ligands and uses thereof
US7141669B2 (en)	2003-04-23	2006-11-28	Pfizer Inc.	Cannabiniod receptor ligands and uses thereof
FR2854633B1 (fr) *	2003-05-07	2005-06-24	Sanofi Synthelabo	Derives de piperidinyl-et piperazinyl-alkylcarbamates, leur preparation et leur application en therapeutique
US7232823B2 (en)	2003-06-09	2007-06-19	Pfizer, Inc.	Cannabinoid receptor ligands and uses thereof
AU2004252109B2 (en)	2003-06-11	2010-04-08	Merck Sharp & Dohme Corp.	Substituted 3-alkyl and 3-alkenyl azetidine derivatives
WO2005000301A1 (en)	2003-06-20	2005-01-06	F. Hoffmann-La Roche Ag	2-aminobenzothiazoles as cb1 receptor inverse agonists
JP4527729B2 (ja)	2003-12-08	2010-08-18	エフ．ホフマン−ラロシュアーゲー	新規チアゾール誘導体
MXPA06008391A (es) *	2004-01-28	2006-08-25	Hoffmann La Roche	Nuevos compuestos espiro-pentaciclicos.
KR100870346B1 (ko)	2004-05-10	2008-11-25	에프. 호프만-라 로슈 아게	비만 치료용 피롤 또는 이미다졸 아마이드
CA2585030A1 (en)	2004-10-27	2006-05-04	F. Hoffmann-La Roche Ag	New indole or benzimidazole derivatives
CA2586068A1 (en)	2004-11-09	2006-05-18	F.Hoffmann-La Roche Ag	Dibenzosuberone derivatives
DK1868999T3 (da)	2005-04-06	2009-08-17	Hoffmann La Roche	Pyridin-3-carboxamidderivater som omvendte CB1-agonister
JP4943826B2 (ja) *	2005-11-25	2012-05-30	田辺三菱製薬株式会社	医薬組成物
US7906652B2 (en)	2005-11-28	2011-03-15	Merck Sharp & Dohme Corp.	Heterocycle-substituted 3-alkyl azetidine derivatives
US7629346B2 (en)	2006-06-19	2009-12-08	Hoffmann-La Roche Inc.	Pyrazinecarboxamide derivatives as CB1 antagonists
AU2007283113A1 (en)	2006-08-08	2008-02-14	Sanofi-Aventis	Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
CA2662084A1 (en)	2006-09-07	2008-03-13	Nycomed Gmbh	Combination treatment for diabetes mellitus
US7781593B2 (en)	2006-09-14	2010-08-24	Hoffmann-La Roche Inc.	5-phenyl-nicotinamide derivatives
AU2008259342B2 (en)	2007-06-04	2014-07-10	Ben-Gurion University Of The Negev Research And Development Authority	Tri-aryl compounds and compositions comprising the same
EP2025674A1 (de)	2007-08-15	2009-02-18	sanofi-aventis	Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
UY31968A (es)	2008-07-09	2010-01-29	Sanofi Aventis	Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
WO2010068601A1 (en)	2008-12-08	2010-06-17	Sanofi-Aventis	A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
KR20120060207A (ko)	2009-08-26	2012-06-11	사노피	신규한 결정성 헤테로방향족 플루오로글리코시드 수화물, 이들 화합물을 포함하는 약제 및 이들의 용도
EP2582709B1 (de)	2010-06-18	2018-01-24	Sanofi	Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
EP2683704B1 (de)	2011-03-08	2014-12-17	Sanofi	Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683702B1 (de)	2011-03-08	2014-12-24	Sanofi	Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2012120058A1 (de)	2011-03-08	2012-09-13	Sanofi	Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8710050B2 (en)	2011-03-08	2014-04-29	Sanofi	Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8871758B2 (en)	2011-03-08	2014-10-28	Sanofi	Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
EP2766349B1 (de)	2011-03-08	2016-06-01	Sanofi	Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
US8809325B2 (en)	2011-03-08	2014-08-19	Sanofi	Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
US8828994B2 (en)	2011-03-08	2014-09-09	Sanofi	Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683703B1 (de)	2011-03-08	2015-05-27	Sanofi	Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EA022342B1 (ru) *	2011-06-10	2015-12-30	КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.	Соединения с активностью антагонистов мускариновых рецепторов и агонистов адренергического рецептора бета2
EP2567959B1 (de)	2011-09-12	2014-04-16	Sanofi	6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridin-4-carbonsäureamid-derivate als kinaseinhibitoren
WO2015068156A1 (en)	2013-11-05	2015-05-14	Ben-Gurion University Of The Negev Research And Development Authority	Compounds for the treatment of diabetes and disease complications arising from same
WO2020033919A1 (en)	2018-08-10	2020-02-13	Diapin Therapeutics, Llc	Tri-peptides and treatment of metabolic, cardiovascular and inflammatory disorders
CN115124447A (zh) *	2022-08-29	2022-09-30	山东诚创蓝海医药科技有限公司	一种3-氮杂环丁酮盐酸盐的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4133881A (en) *	1977-04-27	1979-01-09	A. H. Robins Company, Incorporated	Azetidinyl acetonitrile and acetamide antiarrhythmia compositions and methods
US4242261A (en) *	1979-07-19	1980-12-30	A. H. Robins Company, Inc.	Production of methylene-cycloamines
US4260606A (en) *	1979-07-19	1981-04-07	A. H. Robins Company, Inc.	3-Methyleneazetidine derivatives
US5183902A (en) *	1985-02-28	1993-02-02	A. H. Robins Company, Incorporated	Method of treating muscular tension, muscle spasticity and anxiety with 3-aryloxy and 3-arylthioazetidinecarboxamides
US5151418A (en) *	1985-02-28	1992-09-29	A. H. Robins Company, Incorporated	Method of treating muscular tension, muscle spasticity and anxiety with 3-aryloxy and 3-arylthioazetidinecarboxamides

1998
- 1998-09-11 FR FR9811342A patent/FR2783246B1/fr not_active Expired - Fee Related
1999
- 1999-09-01 TW TW088115056A patent/TW530046B/zh not_active IP Right Cessation
- 1999-09-07 MY MYPI99003867A patent/MY119150A/en unknown
- 1999-09-08 TN TNTNSN99168A patent/TNSN99168A1/fr unknown
- 1999-09-08 DZ DZ990187A patent/DZ2887A1/xx active
- 1999-09-08 MA MA25758A patent/MA26685A1/fr unknown
- 1999-09-09 JP JP2000570149A patent/JP4767413B2/ja not_active Expired - Fee Related
- 1999-09-09 TR TR2001/00693T patent/TR200100693T2/xx unknown
- 1999-09-09 BR BR9913592-2A patent/BR9913592A/pt not_active Application Discontinuation
- 1999-09-09 PL PL346530A patent/PL198526B1/pl not_active IP Right Cessation
- 1999-09-09 CA CA002342739A patent/CA2342739C/fr not_active Expired - Fee Related
- 1999-09-09 WO PCT/FR1999/002147 patent/WO2000015609A1/fr not_active Ceased
- 1999-09-09 ES ES99941728T patent/ES2197666T3/es not_active Expired - Lifetime
- 1999-09-09 EP EP99941728A patent/EP1112251B1/de not_active Expired - Lifetime
- 1999-09-09 DE DE69907698T patent/DE69907698T2/de not_active Expired - Lifetime
- 1999-09-09 HU HU0103341A patent/HUP0103341A3/hu unknown
- 1999-09-09 PT PT99941728T patent/PT1112251E/pt unknown
- 1999-09-09 AT AT99941728T patent/ATE239703T1/de active
- 1999-09-09 AU AU55232/99A patent/AU772025B2/en not_active Ceased
- 1999-09-09 RU RU2001110080/04A patent/RU2230739C2/ru not_active IP Right Cessation
- 1999-09-09 CZ CZ20010883A patent/CZ301446B6/cs not_active IP Right Cessation
- 1999-09-09 CN CNB99810762XA patent/CN1149191C/zh not_active Expired - Fee Related
- 1999-09-09 DK DK99941728T patent/DK1112251T3/da active
- 1999-09-10 CO CO99057627A patent/CO5150230A1/es unknown
- 1999-09-10 AR ARP990104563A patent/AR021483A1/es active IP Right Grant
2001
- 2001-03-08 ZA ZA200102003A patent/ZA200102003B/en unknown

Also Published As

Publication number	Publication date
FR2783246B1 (fr)	2000-11-17
RU2230739C2 (ru)	2004-06-20
WO2000015609A1 (fr)	2000-03-23
DK1112251T3 (da)	2003-09-01
PT1112251E (pt)	2003-09-30
DZ2887A1 (fr)	2003-12-15
DE69907698T2 (de)	2004-03-25
JP2002525267A (ja)	2002-08-13
ZA200102003B (en)	2002-08-28
EP1112251B1 (de)	2003-05-07
TNSN99168A1 (fr)	2005-11-10
BR9913592A (pt)	2001-06-12
FR2783246A1 (fr)	2000-03-17
AU772025B2 (en)	2004-04-08
HUP0103341A3 (en)	2002-10-28
MY119150A (en)	2005-04-30
AR021483A1 (es)	2002-07-24
EP1112251A1 (de)	2001-07-04
HUP0103341A2 (hu)	2002-02-28
CO5150230A1 (es)	2002-04-29
MA26685A1 (fr)	2004-12-20
DE69907698D1 (de)	2003-06-12
CA2342739A1 (fr)	2000-03-23
CZ301446B6 (cs)	2010-03-03
CN1149191C (zh)	2004-05-12
CN1316991A (zh)	2001-10-10
PL346530A1 (en)	2002-02-11
CA2342739C (fr)	2009-09-08
ES2197666T3 (es)	2004-01-01
TR200100693T2 (tr)	2001-07-23
AU5523299A (en)	2000-04-03
PL198526B1 (pl)	2008-06-30
JP4767413B2 (ja)	2011-09-07
CZ2001883A3 (en)	2001-06-13
TW530046B (en)	2003-05-01

Legal Events

Date

Code

Title

Description

2003-11-15

UEP

Publication of translation of european patent specification

Ref document number: 1112251

Country of ref document: EP

Publication	Publication Date	Title
ATE239703T1 (de)	2003-05-15	Azetidinderivate, deren herstellung und sie enthaltende arzneimittel
DE59907961D1 (de)	2004-01-15	Indeno-, naphtho- und benzocyclohepta-dihydrothiazol derivate, deren herstellung und deren verwendung als anorektische arzneimittel
ATE188471T1 (de)	2000-01-15	Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung
ATE353900T1 (de)	2007-03-15	Xanthinderivate, deren herstellung und deren verwendung als arzneimittel
DE69630145D1 (de)	2003-10-30	Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE69903464D1 (de)	2002-11-14	Haftverschlüsse, deren herstellung und sie aufweisenden produkten
ATE256680T1 (de)	2004-01-15	Pyrazol-derivate, ihre herstellung und ihre verwendung in arzneimitteln
ATE299148T1 (de)	2005-07-15	Substituierte isochinolin-3-carbonsäureamide, ihre herstellung und ihre verwendung als arzneimittel
ATE522213T1 (de)	2011-09-15	Fünfgliedrige-heteroringderivate , ihre herstellung und ihre verwendung als arzneimittel
HUP0203190A3 (en)	2003-04-28	Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
EP1202733A4 (de)	2003-05-14	3(5)-amino-pyrazolderivate, deren herstellungsverfahren und verwendung als krebshemmende mittel
ATE261972T1 (de)	2004-04-15	2,5-diazabicyclo(2.2.1)heptanderivate, deren herstellung und deren verwendung in heilkunde
DE59905572D1 (de)	2003-06-18	Substituierte 4-amino-2-aryl-pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
ATE243708T1 (de)	2003-07-15	Substituierte imidazolidinderivate, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
DE50003761D1 (de)	2003-10-23	Indeno-dihydrothiazol derivate, deren herstellung und deren verwendung als anorektische arzneimittel
HUP0105073A3 (en)	2002-10-28	2-aminopyridine derivatives, their use as medicines and pharmaceutical compositions containing them
ATE232879T1 (de)	2003-03-15	Erythromycin-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE69608680D1 (de)	2000-07-06	Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
ATE449786T1 (de)	2009-12-15	Imidazolidinderivate, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
ATE255592T1 (de)	2003-12-15	Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen
HU9700955D0 (en)	1997-07-28	Substituted 2-naphtoylguanidine derivatives, their production, their use and pharmaceutical compositions containing them
DE69610085D1 (de)	2000-10-05	Taxol derivate,deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE60012750D1 (de)	2004-09-09	Neue xanthon derivate, deren herstellung und verwendung als arzneimittel
ATE485271T1 (de)	2010-11-15	Antihistaminische piperidinderivate und zwischenprodukte zu ihrer herstellung
DE69622648D1 (de)	2002-09-05	Benzoxalepin-derivate, deren salze und diese enthaltende arzneimittel